Home » Topics » Regulatory » Patents

Patents
RSS

Bayer claims camptothecin glycoconjugates for use in cancer

Jan. 22, 1999

Integrin receptor antagonists, prodrugs and transdermal iontophoretic administration

Jan. 22, 1999

Novel squalene synthase inhibitors claimed by Nippon Kayaku

Jan. 22, 1999

Compounds for depression and other CNS disorders reported by Akzo Nobel

Jan. 22, 1999

Improved treatments for BPH in development at Pfizer

Jan. 22, 1999

Chugai presents new COX-2 inhibitor series

Jan. 22, 1999

NK1 antagonists in early development at Asahi Glass

Jan. 21, 1999

Antimetastatic bis-indoles described in patent literature

Jan. 21, 1999

D3-selective chromene derivatives synthesized and evaluated at ADIR

Jan. 21, 1999

Nippon Kayaku patents novel squalene synthase inhibitors

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...